Topic
Drugs Controller General of India (DCGI)
Ensuring quality medicines in India: A call to action for patient safety
India’s top drug regulator has expressed serious concern about the quality of medicines in the country. He stressed that the…
Foldax signs manufacturing agreement with Dolphin Life Science India
To enable in-country manufacturing of the TRIA polymer mitral surgical heart valve outside of the US for the first time…
Sun Pharma receives DCGI approval for Molxvir in India
The recommended dose of the drug is 800 mg twice a day for five days Sun Pharmaceutical Industries announced that…
Ampio Pharma receives DCGI approval to commence AP-019 Phase II study in India
The study will utilise inhaled Ampion to treat those suffering from respiratory distress due to COVID-19 Ampio Pharmaceuticals, a biopharmaceutical…
DCGI approves anti-COVID drug developed by DRDO for emergency use
Clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental…
AstraZeneca Pharma gets DCGI nod for lung cancer treatment drug
The oral pill has shown to decrease the risk of cancer recurrence by nearly 83 per cent AstraZeneca Pharma (AstraZeneca…
Bharat Biotech’s COVAXIN approval faces criticism over lack of data
Some industry experts and opposition lawmakers have questioned the approval without publishing efficacy data India on Sunday granted emergency approval…
India approves Oxford-AstraZeneca covid vaccine
The government and the SII are yet to sign an agreement on the purchase of the vaccine The Central Drugs…
Zydus Cadila receives DCGI nod for Saroglitazar Mg
Saroglitazar Mg is used for the treatment of non-alcoholic fatty liver disease Zydus Cadila has received approval from the Drug…
COVID-19 NTF discusses testing, treatment and surveillance of new UK virus strain
The meeting was convened by ICMR, DCGI and other representatives from the Ministry of Health and ICMR as well as…